Actemra is used to treat COVID-19, rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis; cytokine release syndrome, and systemic sclerosis-associated interstitial lung disease.
This reviews covers the literature on tocilizumab (a humanized anti-interleukin-6 receptor antibody. There is sufficient evidence to make it a first-line biologic therapy in rheumatoid arthritis, systemic juvenile inflammatory arthritis, and Castleman's disease. Its efficacy as monotherapy makes it the...
The ACTEMRA-IV data in rheumatoid arthritis (RA) includes 5 double-blind, controlled, multicenter studies. In these studies, patients received doses of ACTEMRA-IV 8 mg per kg monotherapy (288 patients), ACTEMRAIV 8 mg per kg in combination with DMARDs (including methotrexate) (1582 patien...
Summary This reviews covers the literature on tocilizumab (a humanized anti-interleukin-6 receptor antibody. There is sufficient evidence to make it a first-line biologic therapy in rheumatoid arthritis, systemic juvenile inflammatory arthritis, and Castleman's disease. Its efficacy as monotherapy makes...
Summary This reviews covers the literature on tocilizumab (a humanized anti-interleukin-6 receptor antibody. There is sufficient evidence to make it a first-line biologic therapy in rheumatoid arthritis, systemic juvenile inflammatory arthritis, and Castleman's disease. Its efficacy as monotherapy makes...
"ACR Preliminary Definition of Improvement in Rheumatoid Arthritis." Arthritis & Rheumatism. June 1995. American College of Rheumatology. [Cited 2010 Jan 29] Available from: http://www.rheumatology.org/publications/classification/205070.asp?aud=mem12. Actemra(R) [prescribing information]. South San...